Design Therapeutics, Inc. (DSGN)
NASDAQ·Healthcare·Biotechnology
$13.11
+2.74%
Mkt Cap $760.73M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$20.50
Range $20.00 – $21.00
Implied Upside
+56.4%
Consensus $20.50 vs current $13.11
NASDAQ·Healthcare·Biotechnology
$13.11
+2.74%
Mkt Cap $760.73M
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$20.50
Range $20.00 – $21.00
+56.4%
Consensus $20.50 vs current $13.11